Eizo Nanao Technologies is showing a pair of new multipurpose 3-megapixel liquid crystal display monitors at the RSNA meeting. The monitors, released earlier this fall, are now available for sale worldwide.
Eizo Nanao Technologies is showing a pair of new multipurpose 3-megapixel liquid crystal display monitors at the RSNA meeting. The monitors, released earlier this fall, are now available for sale worldwide.
The monochrome RadiForce G33 is designed for PACS, chest radiography, CT, MRI, and angiography. It produces a palette of 8161 gray-scale tones - 4096, or 12 bits, of them can be displayed simultaneously.
The unit incorporates Eizo's aperture modulation technology, which intensifies the differences between black and white tones by enabling a different area ratio for each subpixel. The G33 has a built-in sensor that allows precise remote calibration. Its Digital Uniformity Equalizer unifies the luminance of the backlight.
The color and monochrome RadiForce R31 for CT, MRI, PET, and 3D rendering has a 10-bit color input compatibility that can display up to a trillion colors simultaneously. The R31's image rotation technology permits users to switch easily from landscape to portrait mode. It also eliminates the need for special software for gray-scale rendering without banding or color seepage.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.